Here are six things to know about the issue.
1. Tri-City board members have tentatively decided to exercise the “termination at will” provision in Mr. Moran’s contract.
2. Mr. Moran is not being fired for cause. Therefore, he would receive a severance payment of $525,000 or one year’s salary, plus health and dental coverage for 12 months, if he accepts the offer from Tri-City, according to the report.
3. Tri-City board chairman James Dagostino did not disclose to the San Diego Union-Tribune why Tri-City has decided to split with Mr. Moran. However, Tri-City’s chief marketing officer, David Bennett, told the publication more information will be made available at a later time.
4. The full Tri-City board is set to vote on the matter in open session March 17.
5. In the meantime, Steven Dietlin, CFO of Tri-City, is stepping in for Mr. Moran.
6. The hospital’s decision to split with Mr. Moran comes less than two years after he was hired, and as a collaboration with UC San Diego Health System, which would bring university specialists to Tri-City and also provide access to new classes of patients through certain exclusive health insurance arrangements, is in progress, according to the report.
More articles on executive moves:
Tarek A. Salaway named COO of Mission Hospital: 3 things to know
University of Chicago Medicine hires new associate general counsel: 3 things to know
Baton Rouge Health District names executive director: 4 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
